In our cohort, the patients with severe disease were older and had several comorbidities that could go unnoticed, such as a loss-of-function effect, since no significant differences in the expression of TLR-3 and TLR-7 considering the severity of COVID-19 patients were observed. This evidence concerns the gene TLR3 and COVID-19.